Comparing outcomes with different dialysis modalities in children with kidney failure: home hemodialysis versus in-center hemodiafiltration or conventional hemodialysis.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ahlmann Charlotte, Madden Iona, Busjahn Andreas, Panagiotopoulou Olga, Azukaitis Karolis, Bakkaloglu Sevcan A, Ağbaş Ayşe, Anarat Ali, Askiti Varvara, Bayazit Aysun K, Bulut Ipek Kaplan, Canpolat Nur, Borzych-Duzalka Dagmara, Duzova Ali, Habbig Sandra, Krid Saoussen, Licht Christoph, Litwin Mieczyslaw, Obrycki Lukasz, Paglialonga Fabio, Ranchin Bruno, Samaille Charlotte, Shenoy Mohan, Sinha Manish D, Spasojevic Brankica, Stronach Lynsey, Vidal Enrico, Yilmaz Alev, Fischbach Michel, Schaefer Franz, Schmitt Claus Peter, Oh Jun, Hothi Daljit, Shroff Rukshana
Аннотация
METHODS: Single-center data from HHD patients over 13 years were compared with the multicenter prospective "3H - HDF, Heart and Height" study. Systolic blood pressure [SBP] standard deviation score [SDS], left ventricular mass index [LVMI], height-SDS, biochemical markers, dialysis-related symptoms and medication burden were compared within the HHD cohort and between the three dialysis modalities at baseline and 12 months.
RESULTS: Among 38 HHD patients with complete follow-up, there were no improvements in SBP-SDS, LVMI or height-SDS over 12 months. Serum phosphate levels decreased (median difference -0.15 mmol/L [95% CI -0.5 to -0.1]; p = 0.002) and hemoglobin increased (+ 1.1 g/dL [95% CI 0.3 to 2.0]; p = 0.01). Comparing 38 HHD patients to 55 HDF and 78 HD patients, SBP-SDS, LVMI, and height-SDS were comparable between HHD and HDF at 12 months. LVMI was lower in HHD compared with HD (-11.8 g/m2.16 [95% CI -16.0 to -4.1]; p = 0.003). SBP-SDS and height-SDS were comparable between HHD and HD. PTH and hemoglobin were comparable between HHD and HDF, despite lower phosphate levels in HHD. The frequency of dialysis-related symptoms were comparable between HHD and HDF, and less frequent than in HD.
CONCLUSIONS: In pediatric patients, HHD and HDF showed comparable outcomes for cardiovascular burden, growth, and dialysis-related symptoms, and both demonstrated superior clinical outcomes compared with conventional HD.